Results: 1-25 | 26-29 |
Results: 26-29/29

Authors: Muhlestein, JB
Citation: Jb. Muhlestein, Comment - Infective endocarditis: How well are we managing our patients?, J AM COL C, 33(3), 1999, pp. 794-795

Authors: Anderson, JL Muhlestein, JB Carlquist, J Allen, A Trehan, S Nielson, C Hall, S Brady, J Egger, M Horne, B Lim, T
Citation: Jl. Anderson et al., Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection - The azithromycin in coronary artery disease: Elimination of myocardial infection with Chlamydia (ACADEMIC) study, CIRCULATION, 99(12), 1999, pp. 1540-1547

Authors: Muhlestein, JB
Citation: Jb. Muhlestein, Animal models of chlamydia and atherosclerosis, AM HEART J, 138(5), 1999, pp. S514-S515

Authors: Gilchrist, IC Gardner, LH Muhlestein, JB Arnold, AM Lincoff, AM Califf, RM Tcheng, JE Topol, EJ
Citation: Ic. Gilchrist et al., Effect of institutional volume and academic status on outcomes of coronaryinterventions: The IMPACT-II experience, AM HEART J, 138(5), 1999, pp. 976-982
Risultati: 1-25 | 26-29 |